Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IPILIMUMAB Cause Aspartate aminotransferase increased? 388 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 388 reports of Aspartate aminotransferase increased have been filed in association with IPILIMUMAB (YERVOY). This represents 1.1% of all adverse event reports for IPILIMUMAB.

388
Reports of Aspartate aminotransferase increased with IPILIMUMAB
1.1%
of all IPILIMUMAB reports
68
Deaths
292
Hospitalizations

How Dangerous Is Aspartate aminotransferase increased From IPILIMUMAB?

Of the 388 reports, 68 (17.5%) resulted in death, 292 (75.3%) required hospitalization, and 50 (12.9%) were considered life-threatening.

Is Aspartate aminotransferase increased Listed in the Official Label?

Yes, Aspartate aminotransferase increased is listed as a known adverse reaction in the official FDA drug label for IPILIMUMAB.

What Other Side Effects Does IPILIMUMAB Cause?

Death (3,710) Malignant neoplasm progression (3,296) Diarrhoea (2,557) Off label use (2,097) Colitis (1,988) Pyrexia (1,796) Rash (1,556) Fatigue (1,447) Intentional product use issue (1,329) Nausea (1,169)

What Other Drugs Cause Aspartate aminotransferase increased?

METHOTREXATE (1,600) RITUXIMAB (1,351) ADALIMUMAB (1,166) TOCILIZUMAB (975) ETANERCEPT (939) ACETAMINOPHEN (865) LEFLUNOMIDE (863) INFLIXIMAB (823) ABATACEPT (778) NIVOLUMAB (758)

Which IPILIMUMAB Alternatives Have Lower Aspartate aminotransferase increased Risk?

IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE IPILIMUMAB vs IPRATROPIUM IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS IPILIMUMAB vs IPTACOPAN IPILIMUMAB vs IRBESARTAN

Related Pages

IPILIMUMAB Full Profile All Aspartate aminotransferase increased Reports All Drugs Causing Aspartate aminotransferase increased IPILIMUMAB Demographics